KURA
Price
$6.42
Change
+$0.12 (+1.90%)
Updated
Jun 3 closing price
Capitalization
555.81M
57 days until earnings call
LQDA
Price
$16.53
Change
-$0.34 (-2.02%)
Updated
Jun 3 closing price
Capitalization
1.41B
64 days until earnings call
Interact to see
Advertisement

KURA vs LQDA

Header iconKURA vs LQDA Comparison
Open Charts KURA vs LQDABanner chart's image
Kura Oncology
Price$6.42
Change+$0.12 (+1.90%)
Volume$1.6M
Capitalization555.81M
Liquidia
Price$16.53
Change-$0.34 (-2.02%)
Volume$2.39M
Capitalization1.41B
KURA vs LQDA Comparison Chart
Loading...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KURA vs. LQDA commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Buy and LQDA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (KURA: $6.42 vs. LQDA: $16.53)
Brand notoriety: KURA and LQDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 116% vs. LQDA: 140%
Market capitalization -- KURA: $555.81M vs. LQDA: $1.41B
KURA [@Biotechnology] is valued at $555.81M. LQDA’s [@Biotechnology] market capitalization is $1.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 1 FA rating(s) are green whileLQDA’s FA Score has 0 green FA rating(s).

  • KURA’s FA Score: 1 green, 4 red.
  • LQDA’s FA Score: 0 green, 5 red.
According to our system of comparison, LQDA is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 7 TA indicator(s) are bullish while LQDA’s TA Score has 5 bullish TA indicator(s).

  • KURA’s TA Score: 7 bullish, 1 bearish.
  • LQDA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KURA is a better buy in the short-term than LQDA.

Price Growth

KURA (@Biotechnology) experienced а +14.44% price change this week, while LQDA (@Biotechnology) price change was +5.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

KURA is expected to report earnings on Jul 31, 2025.

LQDA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LQDA($1.41B) has a higher market cap than KURA($556M). LQDA YTD gains are higher at: 40.561 vs. KURA (-26.292). LQDA has higher annual earnings (EBITDA): -122.53M vs. KURA (-177.18M). KURA has more cash in the bank: 658M vs. LQDA (170M). KURA has less debt than LQDA: KURA (19.4M) vs LQDA (148M). KURA has higher revenues than LQDA: KURA (68M) vs LQDA (14.1M).
KURALQDAKURA / LQDA
Capitalization556M1.41B39%
EBITDA-177.18M-122.53M145%
Gain YTD-26.29240.561-65%
P/E RatioN/AN/A-
Revenue68M14.1M482%
Total Cash658M170M387%
Total Debt19.4M148M13%
FUNDAMENTALS RATINGS
KURA vs LQDA: Fundamental Ratings
KURA
LQDA
OUTLOOK RATING
1..100
5869
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
82
Overvalued
PROFIT vs RISK RATING
1..100
10034
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9145
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KURA's Valuation (27) in the Biotechnology industry is somewhat better than the same rating for LQDA (82) in the Pharmaceuticals Major industry. This means that KURA’s stock grew somewhat faster than LQDA’s over the last 12 months.

LQDA's Profit vs Risk Rating (34) in the Pharmaceuticals Major industry is significantly better than the same rating for KURA (100) in the Biotechnology industry. This means that LQDA’s stock grew significantly faster than KURA’s over the last 12 months.

LQDA's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as KURA (100) in the Biotechnology industry. This means that LQDA’s stock grew similarly to KURA’s over the last 12 months.

LQDA's Price Growth Rating (45) in the Pharmaceuticals Major industry is somewhat better than the same rating for KURA (91) in the Biotechnology industry. This means that LQDA’s stock grew somewhat faster than KURA’s over the last 12 months.

LQDA's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as KURA (100) in the Biotechnology industry. This means that LQDA’s stock grew similarly to KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KURALQDA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 20 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GHTMX15.07N/A
N/A
Goldman Sachs International T/M Eq Instl
AHSCX11.33N/A
N/A
Alger Health Sciences C
AUUIX22.19N/A
N/A
AB Select US Equity I
YAFIX19.42N/A
N/A
AMG Yacktman Focused I
WCMIX26.30N/A
N/A
WCM Focused International Growth Instl

LQDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with ALNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
-2.02%
ALNY - LQDA
37%
Loosely correlated
-0.76%
AXON - LQDA
32%
Poorly correlated
+0.07%
AVXL - LQDA
30%
Poorly correlated
+3.70%
XERS - LQDA
29%
Poorly correlated
-7.92%
KURA - LQDA
29%
Poorly correlated
+1.90%
More